Business Wire

B2BROKER

4.4.2024 16:08:35 CEST | Business Wire | Press release

Share
Explore B2Core V2.1 with Enhanced Savings Features, New Trading Platform Integration, Fresh PSPs, and UI Improvements

The latest major upgrade to B2Core was just released by B2Broker, significantly enhancing the platform's back-office and CRM solutions. The V2.1 upgrade delivers on the highly anticipated savings feature, introduces a new trading platform and PSP integrations, and drastically improves the user experience on the platform. Let’s explore:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404452158/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

B2Broker, a leading liquidity and technology provider, has just announced the release of a new version of B2Core, its sophisticated CRM and back-office solution. B2Core V2.1 integrates the TradeLocker trading platform inside its ecosystem, adds new PSPs and enhances the existing ones, and upgrades its UI. (Photo: Business Wire)

Polished UI & Peak Performance

Version 2.1 of B2Core brings a new user interface, major functionality improvements, and technical fixes.

  • A Withdrawal summary provides comprehensive transfer information that features commissions, exchange rates and the net transaction amount.
  • Account creation now enforces minimum deposit settings to maintain consistency in the back-office.
  • On the Deposit, Withdraw, and Transfer pages, accounts in selectors are now categorised by type (e.g., Fiat, Coins, MT4, MT5) for easier navigation.
  • Platform consistency is guaranteed by the Unified Date Format.
  • The old and new UI settings can now be easily switched by users.

Integration with TradeLocker Trading Platform

B2Core introduces TradeLocker, an innovative trading platform seamlessly integrated into the trader's room. This addition enhances the company’s existing suite of integrated platforms, including MetaTrader 4, MetaTrader 5, cTrader and B2Trader, offering brokerages a complex set of trading solutions.

TradeLocker presents a comprehensive suite of powerful trading tools and instruments aiming to cater to a wide spectrum of clients, from novices to seasoned traders. The platform is equipped with versatile features designed to support a variety of trading strategies and preferences, facilitating a seamless and efficient trading experience for brokerage clients.

​​TradeLocker integrates with TradingView to offer a sophisticated charting capability, granting users access to an extensive array of customisable charts and indicators. The platform provides traders with modern tools to manage risks effectively.

Among its standout features are SL & TP Calculator, On-Chart Trading, One-click Trading, Trailing Stop Loss, and Social Mode, enabling traders to efficiently manage their trades engaging with the market. Users can easily develop or customise bots, signals, indicators, and strategies using the TradeLocker AI at TradeLocker Studio.

Payment Improvements and Integrations

Thanks to the V2.1 B2Core update, users now have more transaction options, and the scope of payment integrations has expanded.

Sqala supports deposits and withdrawals in Brazilian reals (BRL). It is renowned for its simplicity, competitive exchange rates, and a convenient dashboard that provides all the essential data. By including Sqala in its portfolio, B2Broker has increased the range of its solutions and fulfilled the needs of customers worldwide.

Transactions have been streamlined and fortified through several new improvements:

  • Within the B2Core environment, BridgerPay provides a better deposit process through an automated data fill-in feature that streamlines transaction processing.
  • Praxis configuration has been enhanced to improve transaction security. To comply with diverse regulatory standards, you can now enable clients from various countries to submit specific documents.
  • The constructor payment adjustments allow clients to attach documents for deposits and withdrawals, ensuring maximum compliance and record accuracy.

The V2.1 upgrade has also brought back access to 1-2-Pay and WireCustom for deposits and withdrawals to expand the choices for transfers.

Engage Customers with Savings Feature

Last but not least, V2.1 adds a savings feature that lets users invest idle funds and get interest over specific periods. The savings programs currently support fixed savings, allowing users to receive fixed-interest rewards. Moreover, admins can access, modify, and initiate new savings programs with the presets page, effortlessly incorporating both business and client preferences.

The savings feature offers flexibility across the board, allowing users to set customised annual interest rates and adjust investment duration with 30-day intervals (30, 60, or 90 days). Brokers may also impose an early withdrawal penalty to maintain the viability of their savings plans.

The savings feature is highly customisable and configurable. The annual interest earnings option will motivate the clients to retain their funds within the broker’s ecosystem. Additionally, it enables brokers to increase fund retention and liquidity within B2Core, resulting in an advantageous situation for everybody involved.

Final Remarks

B2Core continues B2Broker’s mission to deliver quality across all products and services, ensuring maximum client satisfaction. The V2.1 update is another testament to raising industry standards!

The team is working on the complete transition of B2Core to the new interface. Additionally, B2Core intends to offer flexible interest rates for the savings plans. The team also works hard to add new integrations and expansions, allowing clients to enjoy a comprehensive CRM and back-office solutions suite!

Explore B2Core’s new features today and discover the benefits for your business.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240404452158/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye